Claims for Patent: 4,372,747

Summary for Patent: 4,372,747

Title:	Glycohemoglobin determination
Abstract:	A method of measuring glycosylated hemoglobin featuring, in one aspect, providing a sample containing hemoglobin, including an unknown amount of glycosylated hemoglobin, contacting the sample with an oxidizing agent to generate formaldehyde, and measuring the formaldehyde as a measure of glycosylated hemoglobin, the measuring being carried out by reacting the formaldehyde with a water-soluble amine or an ammonium salt and a .beta.-diketone to generate a fluorescent compound whose fluorescence is measured as a measure of glycosylated hemoglobin.
Inventor(s):	Gabbay; Kenneth (Chestnut Hill, MA), Gallop; Paul M. (Chestnut, MA)
Assignee:	Children\'s Hospital Medical Center (Boston, MA)
Application Number:	06/288,777
Patent Claims:	1. A method of measuring glycosylated hemoglobin comprising providing a sample containing hemoglobin including an unknown quantity of glycosylated hemoglobin, contacting said sample with an oxidizing agent to generate formaldehyde, and measuring said formaldehyde as a measure of said unknown quantity of glycosylated hemoglobin, said measuring being carried out by reacting said formaldehyde with a water-soluble amine or an ammonium salt and a .beta.-diketone to generate a fluorescent compound, the fluorescence of which is measured as a measure of said glycosylated hemoglobin. 2. The method of claim 1 wherein said ammonium salt is ammonium acetate and said .beta.-diketone is acetylacetone. 3. The method of claim 2 wherein said ammonium acetate and said acetylacetone are combined, prior to reacting them with said formaldehyde, to form a formaldehyde detection reagent which is about 2 M ammonium acetate and about 0.02 M acetylacetone. 4. A method of measuring glycosylated hemoglobin comprising providing a sample containing hemoglobin including an unknown quantity of glycosylated hemoglobin, contacting said sample with tetrahydrofuran to remove hemin and precipitate globin, contacting said globin with an oxidizing agent to generate formaldehyde, and measuring said formaldehyde as a measure of said unknown quantity of glycosylated hemoglobin. 5. The method of claim 4 wherein said tetrahydrofuran is mixed with an acid. 6. The method of claim 5 wherein said tetrahydrofuran is about 1% in about 12 N HCl. 7. A method of measuring glycosylated hemoglobin comprising providing a sample containing hemoglobin including an unknown quantity of glycosylated hemoglobin, contacting said sample with periodate to generate formaldehyde, contacting said sample with zinc sulfate to remove excess periodate, and measuring said formaldehyde as a measure of said unknown quantity of glycosylated hemoglobin.

Details for Patent 4,372,747

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	July 20, 1983	4,372,747	2001-07-31